OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights OmniAb (NASDAQ: OABI) reported fourth-quarter and full-year 2025 results and provided 2026 guidance on March 4, 2026. Full-year 2025 revenue was $18.7M with a net loss of $64.8M and cash, equivalents and short-term investments of $54.0M at year-end.The company exited 2025 with 107 active partners, 407 active programs and launched OmniUltra. 2026 guidance is revenue of $25–30M, operating expenses of $80–85M, cash costs of $50–55M, and expected year-end cash of $30–35M.

#OABI OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

www.stocktitan.net/news/OABI/omni-ab-report...

OABI endurece controles y advierte que actuará penalmente ante cualquier intento de usurpación de bienes incautados Tegucigalpa, Francisco Morazán. – La Oficina Administradora de Bienes Incautados (OABI) marcó un giro firme en su postura institucional al advertir que no permitirá tomas ilegales, usurpaciones ni ocupaciones arbitrarias de propiedades bajo administración estatal, una problemática que en años recientes ha generado tensiones y disputas en distintos puntos del país. En un comunicado, la […] Este artículo OABI endurece controles y advierte que actuará penalmente ante cualquier intento de usurpación de bienes incautados se publicó primero en Diario El Mundo | Noticias de Honduras y el Mundo.

#Nacionales #Bienesincautados #OABI OABI endurece controles y advierte que actuará penalmente ante cualquier intento de usurpación de bienes incautados

Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies OmniAb (NASDAQ: OABI) launched OmniUltra on December 15, 2025, described as the industry’s first transgenic chicken engineered to express ultralong CDRH3 domains on a human antibody framework.OmniUltra generates human immune repertoires with cow-inspired ultralong CDRH3s and isolates picobodies™ (4–6 kDa), enabling antibodies and peptide therapeutics for bispecifics, CAR-T, radioligands and standalone peptides. The company presented at AET 2025 and will host a Virtual Investor Event today at 5:00 p.m. ET with slides and a replay on its investor site.

#OABI Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

www.stocktitan.net/news/OABI/launch-of-omni...

#OABI OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

www.stocktitan.net/news/OABI/omni-ab-report...

$30 Million Capital Raise: OmniAb's Strategic Private Placement Draws Top-Tier Investors and Insiders Biotech firm OmniAb to issue 21.25M shares at $1.40/share, with officers and directors participating at $1.85/share. Closing expected August 26, 2025, with Leerink Partners as placement agent.

#OABI OmniAb Announces $30 Million Private Placement

www.stocktitan.net/news/OABI/omni-ab-announ...

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights OmniAb (NASDAQ: OABI) reported Q2 2025 financial results, showing revenue of $3.9 million, down from $7.6 million in Q2 2024. The company posted a net loss of $15.9 million ($0.15 per share). Despite lower revenue, OmniAb achieved significant business milestones, reaching 100 active partners and 381 active programs, including 32 OmniAb-derived programs in clinical development or commercialization.The company launched the xPloration® Partner Access Program and entered six new license agreements. Notable highlights include partner Immunovant initiating Phase 3 trials for IMVT-1402, and Johnson & Johnson's JNJ-5322 showing 100% overall response rate in initial Phase 1 results. OmniAb maintains its 2025 revenue guidance of $20-25 million and expects operating expenses of $85-90 million.

#OABI OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

www.stocktitan.net/news/OABI/omni-ab-report...

OABI toma control de bienes de Romeo Vásquez Velásquez por orden judicial Las autoridades hondureñas han dado un paso significativo en el proceso judicial contra el general en condición de retiro Romeo Vásquez Velásquez. La Oficina Administradora de Bienes Incautados (OABI) confirmó este martes que ha recibido instrucciones para tomar el control administrativo de un conjunto de bienes pertenecientes al exjefe del Estado Mayor Conjunto. Este artículo OABI toma control de bienes de Romeo Vásquez Velásquez por orden judicial se publicó primero en Diario El Mundo | Noticias de Honduras y el Mundo.

#Nacionales #Bienes #OABI OABI toma control de bienes de Romeo Vásquez Velásquez por orden judicial

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with improving money flow, Wed Jul 9th - #XLO #TAOX #SBC #RAIL #PAHC #OABI #KALA #INBX #GSIT #CNXN #AZTA #LDI #GGT #DK #CPUH #BGR #ALUR - More: crystalequityresearch.com/SmCpStr/ - #smallcap

OABI decomisa 10 vehículos de Koriun con valor estimado de hasta 5 millones de lempiras Tegucigalpa – El director ejecutivo de la Oficina Administradora de Bienes Incautados (OABI), Marco Zelaya, confirmó este jueves que tras el allanamiento a las oficinas de Koriun Inversiones de Choloma su entidad decomisó 10 vehículos, cantidad menor a las 15 unidades originalmente reportadas en el operativo inicial. «Fuimos informados por la autoridad que fuéramos a […] Este artículo OABI decomisa 10 vehículos de Koriun con valor estimado de hasta 5 millones de lempiras se publicó primero en Diario El Mundo | Noticias de Honduras y el Mundo.

#Nacionales #Inversiones #Bienesincautados #OABI OABI decomisa 10 vehículos de Koriun con valor estimado de hasta 5 millones de lempiras

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit OmniAb, Inc. today announced its participation in the 21 st Annual PEGS Boston– The Essential Protein& Antibody Engineering Summit underway at the Omni Hotel. Earlier today, the company showcased case studies utilizing xPloration, a high-throughput single B-cell screening platform that harnesses machine learning and computer vision artificial...

#OABI OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

www.stocktitan.net/news/OABI/omni-ab-showca...

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights OmniAb (NASDAQ: OABI) reported Q1 2025 financial results with revenue of $4.2 million, up from $3.8 million in Q1 2024. The company posted a net loss of $18.2 million ($0.17 per share), compared to $19.0 million loss in Q1 2024. Key highlights include: three new platform license agreements, 95 active partners, and 378 active programs. The company affirmed 2025 revenue guidance of $20-25 million and revised operating expenses to $85-90 million. Notable developments include a $3 million upfront payment from Angelini Pharma deal with potential milestones over $170 million, and the launch of xPloration® Partner Access Program. Partner updates include positive clinical results for Immunovant's IMVT-1402 and batoclimab programs, and CStone's EMA submission for sugemalimab in NSCLC treatment.

#OABI OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

www.stocktitan.net/news/OABI/omni-ab-report...

OmniAb Introduces the xPloration® Partner Access Program OmniAb (NASDAQ: OABI) has launched the xPloration Partner Access Program, allowing current partners to purchase their proprietary high-throughput single B-cell screening platform. The xPloration instrument leverages machine learning and AI to enhance antibody discovery and development capabilities.The platform features custom chips with 1.5 million microcapillaries for B-cell isolation and completes instrument runs in approximately 1.5 hours. Key advantages include superior processing speed, exceptional hit recovery, and enhanced discovery efficiency through laser-based recovery and advanced functional screening assays. The technology will be showcased at the 21st Annual PEGS Boston Summit (May 12-16, 2025) through presentations by Dr. Bob Chen and Dr. John Kenney.

#OABI OmniAb Introduces the xPloration® Partner Access Program

www.stocktitan.net/news/OABI/omni-ab-introd...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with strong volume declines, Wed Mar 19th - #REE #LOB #WALD #HUYA #CMLS #IMG #PFC #OABI #INFN - More: crystalequityresearch.com/SmCpStr/ - #smallcap

OmniAb Doubles Q4 Revenue, Expands to 363 Drug Discovery Programs OmniAb reports 125% Q4 revenue growth with 363 active programs and 32 clinical-stage assets. Company expands biotech partnerships while launching new OmniHub platform.

#OABI OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

www.stocktitan.net/news/OABI/omni-ab-report...

Titular de OABI denuncia estafadores que usan nombre de la institución para fraudes inmobiliarios El director de la Oficina Administradora de Bienes Incautados (OABI), Marco Zelaya, ha presentado una denuncia formal ante el Ministerio Público contra organizaciones criminales que están suplantando la identidad de la institución para cometer estafas…

#Nacionales #OABI #fraudes #Inmobiliarios Titular de OABI denuncia estafadores que usan nombre de la institución para fraudes inmobiliarios

OmniAb Unveils Revolutionary AI-Powered Antibody Discovery Platform, Launches Advanced OmniHub™ Portal OmniAb showcases groundbreaking AI-enhanced antibody discovery technology and introduces OmniHub™, a cutting-edge bioinformatics platform revolutionizing partner collaboration.

#OABI OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference

www.stocktitan.net/news/OABI/omni-ab-techno...

Revelaciones de Los Cachiros en EE.UU. obligan a Fiscalía hondureña a investigar, afirma director de OABI La justicia hondureña enfrenta un nuevo desafío tras las declaraciones de Devis Leonel Rivera Maradiaga, líder de la organización criminal Los Cachiros, en una corte estadounidense. Este artículo Revelaciones de Los Cachiros en EE.UU. obligan a…

#Nacionales #losCachiros #Fiscalía #OABI Revelaciones de Los Cachiros en EE.UU. obligan a Fiscalía hondureña a investigar, afirma director de OABI